{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T11:06:47Z","timestamp":1794049607218,"version":"4.8.0"},"reference-count":82,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T00:00:00Z","timestamp":1755302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Little Green Pharma Ltd., Perth, Australia"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Current therapies for inflammatory bowel disease (IBD), such as olsalazine and cyclosporine, often exhibit limited long-term efficacy and are associated with adverse effects. Cannabidiol (CBD), a non-psychoactive phytocannabinoid, shows promise for its anti-inflammatory properties, though its effectiveness as a monotherapy remains inconclusive. This study investigates the therapeutic potential of combining low-dose CBD (10 mg\/kg) with olsalazine (50 mg\/kg) or cyclosporine (2.5, 5 mg\/kg) in dextran sulphate sodium (DSS)-induced acute and chronic colitis models in mice. Disease severity was assessed via disease activity index (DAI), colon morphology, cytokine and chemokine expression, myeloperoxidase (MPO) activity, systemic inflammatory markers, and glucagon-like peptide-1 (GLP-1) regulation. Safety evaluations included haematology and plasma biochemistry. DSS-treated mice showed elevated DAI scores, colon shortening, heightened inflammation, and organ enlargement. Combination therapies significantly ameliorated colitis, reducing DAI, MPO activity, and inflammatory cytokines, while restoring colon length and GLP-1 levels\u2014without inducing liver or kidney toxicity. These findings demonstrate that combining a low dose of CBD with standard IBD drugs enhances therapeutic efficacy while minimizing side effects, supporting its integration into future combination strategies for more effective and safer IBD management.<\/jats:p>","DOI":"10.3390\/ijms26167913","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T16:22:33Z","timestamp":1755534153000},"page":"7913","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Cannabidiol Enhances the Therapeutic Efficacy of Olsalazine and Cyclosporine in a Murine Model of Colitis"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5430-825X","authenticated-orcid":false,"given":"Dinesh","family":"Thapa","sequence":"first","affiliation":[{"name":"Curtin Medical Research Institute, Curtin University, Perth, WA 6102, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohan","family":"Patil","sequence":"additional","affiliation":[{"name":"Curtin Medical Research Institute, Curtin University, Perth, WA 6102, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon N.","family":"Warne","sequence":"additional","affiliation":[{"name":"Curtin Medical Research Institute, Curtin University, Perth, WA 6102, Australia"},{"name":"College of Science, Health, Engineering and Education, Murdoch University, Perth, WA 6150, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0038-7391","authenticated-orcid":false,"given":"Rodrigo","family":"Carlessi","sequence":"additional","affiliation":[{"name":"Curtin Medical Research Institute, Curtin University, Perth, WA 6102, Australia"},{"name":"Harry Perkins Institute of Medical Research, QEII Medical Centre for Medical Research, The University of Western Australia, Nedlands, WA 6009, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9801-7235","authenticated-orcid":false,"given":"Marco","family":"Falasca","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, University of Parma, 43125 Parma, Italy"},{"name":"Molecular Endocrinology and Pharmacology, Harry Perkins Institute of Medical Research and Centre for Medical Research, The University of Western Australia, Nedlands, WA 6009, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/nrgastro.2015.150","article-title":"The Global Burden of IBD: From 2015 to 2025","volume":"12","author":"Kaplan","year":"2015","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S2468-1253(19)30333-4","article-title":"The Global, Regional, and National Burden of Inflammatory Bowel Disease in 195 Countries and Territories, 1990\u20132017: A Systematic Analysis for the Global Burden of Disease Study 2017","volume":"5","author":"Alatab","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e065186","DOI":"10.1136\/bmjopen-2022-065186","article-title":"Global, Regional and National Burden of Inflammatory Bowel Disease in 204 Countries and Territories from 1990 to 2019: A Systematic Analysis Based on the Global Burden of Disease Study 2019","volume":"13","author":"Wang","year":"2023","journal-title":"BMJ Open"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nrgastro.2017.136","article-title":"Environmental Triggers in IBD: A Review of Progress and Evidence","volume":"15","author":"Ananthakrishnan","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nrgastro.2017.110","article-title":"The IBD Interactome: An Integrated View of Aetiology, Pathogenesis and Therapy","volume":"14","author":"Fiocchi","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1113\/JP275396","article-title":"The Interplay between Microbes and the Immune Response in Inflammatory Bowel Disease","volume":"596","author":"Goethel","year":"2018","journal-title":"J. Physiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrgastro.2017.88","article-title":"Gut Microbiota and IBD: Causation or Correlation?","volume":"14","author":"Ni","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1053\/j.gastro.2019.04.016","article-title":"Environmental Risk Factors for Inflammatory Bowel Diseases: An Umbrella Review of Meta-Analyses","volume":"157","author":"Piovani","year":"2019","journal-title":"Gastroenterology"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Al-Bawardy, B., Shivashankar, R., and Proctor, D.D. (2021). Novel and Emerging Therapies for Inflammatory Bowel Disease. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.651415"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"493012","DOI":"10.1155\/2015\/493012","article-title":"Inflammatory Bowel Disease: An Overview of Immune Mechanisms and Biological Treatments","volume":"2015","author":"Garcia","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1056\/NEJMra2002697","article-title":"Pathophysiology of Inflammatory Bowel Diseases","volume":"383","author":"Chang","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Yeshi, K., Jamtsho, T., and Wangchuk, P. (2024). Current Treatments, Emerging Therapeutics, and Natural Remedies for Inflammatory Bowel Disease. Molecules, 29.","DOI":"10.3390\/molecules29163954"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1756284820927550","DOI":"10.1177\/1756284820927550","article-title":"Complementary and Alternative Medications in the Management of Inflammatory Bowel Disease","volume":"13","author":"Picardo","year":"2020","journal-title":"Ther. Adv. Gastroenterol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1053\/j.gastro.2021.04.068","article-title":"Rational Combination Therapy to Overcome the Plateau of Drug Efficacy in Inflammatory Bowel Disease","volume":"161","author":"Stalgis","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.cgh.2015.02.019","article-title":"Curcumin in Combination with Mesalamine Induces Remission in Patients with Mild-to-Moderate Ulcerative Colitis in a Randomized Controlled Trial","volume":"13","author":"Lang","year":"2015","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Thapa, D., Patil, M., Warne, L.N., Carlessi, R., and Falasca, M. (2024). Comprehensive Assessment of Cannabidiol and HU308 in Acute and Chronic Colitis Models: Efficacy, Safety, and Mechanistic Innovations. Cells, 13.","DOI":"10.3390\/cells13232013"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Thapa, D., Warne, L.N., and Falasca, M. (2023). Pharmacohistory of Cannabis Use-A New Possibility in Future Drug Development for Gastrointestinal Diseases. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241914677"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00213-020-05712-8","article-title":"Cannabidiol: Pharmacology and Therapeutic Targets","volume":"238","author":"Britch","year":"2021","journal-title":"Psychopharmacology"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Castillo-Arellano, J., Canseco-Alba, A., Cutler, S.J., and Le\u00f3n, F. (2023). The Polypharmacological Effects of Cannabidiol. Molecules, 28.","DOI":"10.3390\/molecules28073271"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"106025","DOI":"10.1016\/j.phrs.2021.106025","article-title":"Modulatory Role of the Endocannabinoidome in the Pathophysiology of the Gastrointestinal Tract","volume":"175","author":"Lian","year":"2022","journal-title":"Pharmacol. Res."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Hryhorowicz, S., Kaczmarek-Ry\u015b, M., Zieli\u0144ska, A., Scott, R.J., S\u0142omski, R., and P\u0142awski, A. (2021). Endocannabinoid System as a Promising Therapeutic Target in Inflammatory Bowel Disease\u2014A Systematic Review. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.790803"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Thapa, D., Ghimire, A., Warne, L.N., and Carlessi, R. (2025). Targeting the Endocannabinoidome: A Novel Approach to Managing Extraintestinal Complications in Inflammatory Bowel Disease. Pharmaceuticals, 18.","DOI":"10.3390\/ph18040478"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"5734","DOI":"10.1002\/ptr.7232","article-title":"The Emerging Role of Cannabidiol (CBD) Products; a Survey Exploring the Public\u2019s Use and Perceptions of CBD","volume":"35","author":"Bhamra","year":"2021","journal-title":"Phytother. Res."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"De Filippis, D., Esposito, G., Cirillo, C., Cipriano, M., De Winter, B.Y., Scuderi, C., Sarnelli, G., Cuomo, R., Steardo, L., and De Man, J.G. (2011). Cannabidiol Reduces Intestinal Inflammation through the Control of Neuroimmune Axis. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0028159"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.bcp.2013.01.017","article-title":"Beneficial Effect of the Non-Psychotropic Plant Cannabinoid Cannabigerol on Experimental Inflammatory Bowel Disease","volume":"85","author":"Borrelli","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/j.1476-5381.2010.00791.x","article-title":"The Effects of \u03949-Tetrahydrocannabinol and Cannabidiol Alone and in Combination on Damage, Inflammation and in Vitro Motility Disturbances in Rat Colitis: \u03949-Tetrahydrocannabinol and Cannabidiol in Rat Colitis","volume":"160","author":"Jamontt","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1089\/can.2016.0034","article-title":"An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal Studies","volume":"2","author":"Iffland","year":"2017","journal-title":"Cannabis Cannabinoid Res."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Cai, Z., Wang, S., and Li, J. (2021). Treatment of Inflammatory Bowel Disease: A Comprehensive Review. Front. Med., 8.","DOI":"10.3389\/fmed.2021.765474"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"175719","DOI":"10.1016\/j.ejphar.2023.175719","article-title":"Aminosalicylates Target GPR35, Partly Contributing to the Prevention of DSS-Induced Colitis","volume":"949","author":"Otkur","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2165\/00002018-200023050-00006","article-title":"Comparative Tolerability of Treatments for Inflammatory Bowel Disease","volume":"23","author":"Stein","year":"2000","journal-title":"Drug Saf."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.1038\/cddis.2011.36","article-title":"Gemcitabine\/Cannabinoid Combination Triggers Autophagy in Pancreatic Cancer Cells through a ROS-Mediated Mechanism","volume":"2","author":"Donadelli","year":"2011","journal-title":"Cell Death Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"6368","DOI":"10.1038\/s41388-018-0390-1","article-title":"GPR55 Signalling Promotes Proliferation of Pancreatic Cancer Cells and Tumour Growth in Mice, and Its Inhibition Increases Effects of Gemcitabine","volume":"37","author":"Ferro","year":"2018","journal-title":"Oncogene"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"118916","DOI":"10.1016\/j.ijpharm.2019.118916","article-title":"CBD Loaded Microparticles as a Potential Formulation to Improve Paclitaxel and Doxorubicin-Based Chemotherapy in Breast Cancer","volume":"574","year":"2020","journal-title":"Int. J. Pharm."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/3-540-26573-2_2","article-title":"Cannabinoid Receptor Signaling","volume":"168","author":"Howlett","year":"2005","journal-title":"Handb. Exp. Pharmacol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Tadijan, A., Vla\u0161i\u0107, I., Vlaini\u0107, J., \u0110iki\u0107, D., Or\u0161oli\u0107, N., and Jazvin\u0161\u0107ak Jembrek, M. (2022). Intracellular Molecular Targets and Signaling Pathways Involved in Antioxidative and Neuroprotective Effects of Cannabinoids in Neurodegenerative Conditions. Antioxidants, 11.","DOI":"10.3390\/antiox11102049"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Suryavanshi, S.V., Kovalchuk, I., and Kovalchuk, O. (2021). Cannabinoids as Key Regulators of Inflammasome Signaling: A Current Perspective. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.613613"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"284","DOI":"10.2174\/1570159X20666220411101217","article-title":"The NLRP3 Inflammasome in Stress Response: Another Target for the Promiscuous Cannabidiol","volume":"21","author":"Hartmann","year":"2023","journal-title":"Curr. Neuropharmacol."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Xu, Q., Yao, Y., Liu, Y., Zhang, J., and Mao, L. (2023). The Mechanism of Traditional Medicine in Alleviating Ulcerative Colitis: Regulating Intestinal Barrier Function. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1228969"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Franco Leal, R., and Torriani, T. (2020). Traditional Drugs: Mechanisms of Immunosuppressor and Corticosteroid Therapies for Inflammatory Bowel Diseases. Biological Therapy for Inflammatory Bowel Disease, IntechOpen.","DOI":"10.5772\/intechopen.83074"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cytogfr.2023.07.001","article-title":"Recent Advances in the Treatment of IBD: Targets, Mechanisms and Related Therapies","volume":"71","author":"Liu","year":"2023","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"3094642","DOI":"10.1155\/2016\/3094642","article-title":"Anti-Inflammatory Effects of GLP-1-Based Therapies beyond Glucose Control","volume":"2016","author":"Lee","year":"2016","journal-title":"Mediat. Inflamm."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"8044","DOI":"10.18632\/aging.204953","article-title":"The Alleviating Effect and Mechanism of GLP-1 on Ulcerative Colitis","volume":"15","author":"Wang","year":"2023","journal-title":"Aging"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Thapa, D., Patil, M., Warne, L.N., Carlessi, R., and Falasca, M. (2025). Enhancing Tetrahydrocannabinol\u2019s Therapeutic Efficacy in Inflammatory Bowel Disease: The Roles of Cannabidiol and the Cannabinoid 1 Receptor Allosteric Modulator ZCZ011. Pharmaceuticals, 18.","DOI":"10.3390\/ph18020148"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"40","DOI":"10.33590\/emjinnov\/21-00134","article-title":"Current Therapy in Inflammatory Bowel Disease: Why and How We Need to Change?","volume":"6","author":"Falloon","year":"2022","journal-title":"EMJ Innov."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/MOG.0b013e328354567f","article-title":"Immunosuppression in Inflammatory Bowel Disease: How Much Is Too Much?","volume":"28","author":"Cohen","year":"2012","journal-title":"Curr. Opin. Gastroenterol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1053\/j.gastro.2016.09.046","article-title":"Management Strategies to Improve Outcomes of Patients with Inflammatory Bowel Diseases","volume":"152","author":"Colombel","year":"2017","journal-title":"Gastroenterology"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0162-3109(00)00192-2","article-title":"Mechanisms of Action of Cyclosporine","volume":"47","author":"Matsuda","year":"2000","journal-title":"Immunopharmacology"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S0025-6196(12)60930-6","article-title":"Cyclosporine Treatment of Inflammatory Bowel Disease","volume":"67","author":"Sandborn","year":"1992","journal-title":"Mayo Clin. Proc."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Fukuda, T., Naganuma, M., Sugimoto, S., Nanki, K., Mizuno, S., Mutaguchi, M., Nakazato, Y., Inoue, N., Ogata, H., and Iwao, Y. (2017). The Risk Factor of Clinical Relapse in Ulcerative Colitis Patients with Low Dose 5-Aminosalicylic Acid as Maintenance Therapy: A Report from the IBD Registry. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0187737"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.lfs.2013.01.028","article-title":"Efficacy of Drugs Used in the Treatment of IBD and Combinations Thereof in Acute DSS-Induced Colitis in Mice","volume":"92","author":"Sann","year":"2013","journal-title":"Life Sci."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1136\/gut.2006.103564","article-title":"Risks and Benefits of Biologic Therapy for Inflammatory Bowel Diseases","volume":"56","year":"2007","journal-title":"Gut"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Jefremow, A., and Neurath, M.F. (2023). Novel Small Molecules in IBD: Current State and Future Perspectives. Cells, 12.","DOI":"10.3390\/cells12131730"},{"key":"ref_53","first-page":"3364","article-title":"Multiple Mechanisms Involved in the Large-Spectrum Therapeutic Potential of Cannabidiol in Psychiatric Disorders","volume":"367","author":"Campos","year":"2012","journal-title":"Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"J\u00eetc\u0103, G., \u0150sz, B.E., Vari, C.E., Rusz, C.-M., Tero-Vescan, A., and Pu\u0219ca\u0219, A. (2023). Cannabidiol: Bridge between Antioxidant Effect, Cellular Protection, and Cognitive and Physical Performance. Antioxidants, 12.","DOI":"10.3390\/antiox12020485"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Blaskovich, M.A.T., Kavanagh, A.M., Elliott, A.G., Zhang, B., Ramu, S., Amado, M., Lowe, G.J., Hinton, A.O., Pham, D.M.T., and Zuegg, J. (2021). The Antimicrobial Potential of Cannabidiol. Commun. Biol., 4.","DOI":"10.1038\/s42003-020-01530-y"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1053\/gast.2000.19458","article-title":"Suppression of NF-\u03baB Activity by Sulfasalazine Is Mediated by Direct Inhibition of I\u03baB Kinases \u03b1 and \u03b2","volume":"119","author":"Weber","year":"2000","journal-title":"Gastroenterology"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2147\/ITT.S263690","article-title":"Cannabidiol as a Novel Therapeutic for Immune Modulation","volume":"9","author":"Peyravian","year":"2020","journal-title":"ImmunoTargets Ther."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1089\/can.2017.0041","article-title":"The Cannabinoids Delta(8)THC, CBD, and HU-308 Act via Distinct Receptors to Reduce Corneal Pain and Inflammation","volume":"3","author":"Thapa","year":"2018","journal-title":"Cannabis Cannabinoid Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.3748\/wjg.v20.i12.3208","article-title":"Interleukin and Interleukin Receptor Gene Polymorphisms in Inflammatory Bowel Diseases Susceptibility","volume":"20","author":"Magyari","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/ibd.20339","article-title":"Role of the Novel Th17 Cytokine IL-17F in Inflammatory Bowel Disease (IBD): Upregulated Colonic IL-17F Expression in Active Crohn\u2019s Disease and Analysis of the IL17F p.His161Arg Polymorphism in IBD","volume":"14","author":"Seiderer","year":"2008","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.dld.2004.09.013","article-title":"Dose Escalation of 5ASA: Does it work?","volume":"37","author":"Travis","year":"2005","journal-title":"Dig. Liver Dis."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1084\/jem.20041948","article-title":"Intestinal Antiinflammatory Effect of 5-Aminosalicylic Acid Is Dependent on Peroxisome Proliferator-Activated Receptor-Gamma","volume":"201","author":"Rousseaux","year":"2005","journal-title":"J. Exp. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1111\/bph.13497","article-title":"An Update on PPAR Activation by Cannabinoids","volume":"173","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"154771","DOI":"10.1016\/j.phymed.2023.154771","article-title":"Cannabidiol Goes Nuclear: The Role of PPAR\u03b3","volume":"114","author":"Khosropoor","year":"2023","journal-title":"Phytomedicine"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s44446-025-00005-7","article-title":"Cannabidiol as an Immune Modulator: A Comprehensive Review","volume":"33","author":"Mujahid","year":"2025","journal-title":"Saudi Pharm. J."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2350825","DOI":"10.1002\/eji.202350825","article-title":"The Immunosuppressive Drug Cyclosporin A Has an Immunostimulatory Function in CD8+ T Cells","volume":"54","author":"Hering","year":"2024","journal-title":"Eur. J. Immunol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"105769","DOI":"10.1016\/j.neuint.2024.105769","article-title":"Cannabidiol Prevents LPS-Induced Inflammation by Inhibiting the NLRP3 Inflammasome and iNOS Activity in BV2 Microglia Cells via CB2 Receptors and PPAR\u03b3","volume":"177","author":"Rodrigues","year":"2024","journal-title":"Neurochem. Int."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Ke, P., Shao, B.-Z., Xu, Z.-Q., Wei, W., Han, B.-Z., Chen, X.-W., Su, D.-F., and Liu, C. (2016). Activation of Cannabinoid Receptor 2 Ameliorates DSS-Induced Colitis through Inhibiting NLRP3 Inflammasome in Macrophages. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0155076"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2300446","DOI":"10.1002\/mnfr.202300446","article-title":"Dietary Cannabidiol Activates PKA\/AMPK Signaling and Attenuates Chronic Inflammation and Leaky Gut in DSS-Induced Colitis Mice","volume":"68","author":"Sun","year":"2024","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Hunt, J.E., Holst, J.J., Jeppesen, P.B., and Kissow, H. (2021). GLP-1 and Intestinal Diseases. Biomedicines, 9.","DOI":"10.3390\/biomedicines9040383"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"100979","DOI":"10.1016\/j.eclinm.2021.100979","article-title":"GLP-1 Based Therapies and Disease Course of Inflammatory Bowel Disease","volume":"37","author":"Villumsen","year":"2021","journal-title":"eClinicalMedicine"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Adlimoghaddam, A., Sabbir, M.G., and Albensi, B.C. (2016). Ammonia as a Potential Neurotoxic Factor in Alzheimer\u2019s Disease. Front. Mol. Neurosci., 9.","DOI":"10.3389\/fnmol.2016.00057"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"101361","DOI":"10.1016\/j.jceh.2024.101361","article-title":"The Story of Ammonia in Liver Disease: An Unraveling Continuum","volume":"14","author":"Anand","year":"2024","journal-title":"J. Clin. Exp. Hepatol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.2169\/internalmedicine.2366-23","article-title":"Drug-induced Interstitial Nephritis in a Patient with Ulcerative Colitis Treated with 5-Aminosalicylic Acid","volume":"63","author":"Hayashi","year":"2024","journal-title":"Intern. Med."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1159\/000188024","article-title":"Interstitial Nephritis Associated with 5-Aminosalicyclic Acid","volume":"67","author":"Witte","year":"1994","journal-title":"Nephron"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Pagano, E., Capasso, R., Piscitelli, F., Romano, B., Parisi, O.A., Finizio, S., Lauritano, A., Marzo, V.D., Izzo, A.A., and Borrelli, F. (2016). An Orally Active Cannabis Extract with High Content in Cannabidiol Attenuates Chemically-Induced Intestinal Inflammation and Hypermotility in the Mouse. Front. Pharmacol., 7.","DOI":"10.3389\/fphar.2016.00341"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Han, H., Gao, M., Wang, F., Luo, Z., Jiang, X., Qiu, Y., Su, J., Duan, X., Luo, S., and Tang, S. (2024). Protective Effects of Patchouli Alcohol against DSS-Induced Ulcerative Colitis. Sci. Rep., 14.","DOI":"10.1038\/s41598-024-66259-8"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"985","DOI":"10.21037\/atm-22-4082","article-title":"Cannabidiol Attenuates Methamphetamine-Induced Cardiac Inflammatory Response through the PKA\/CREB Pathway in Rats","volume":"10","author":"Nie","year":"2022","journal-title":"Ann. Transl. Med."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0090-9556(25)07598-1","article-title":"Bioavailability Assessment of Cyclosporine in the Rat. Influence of Route of Administration","volume":"18","author":"Luke","year":"1990","journal-title":"Drug Metab. Dispos."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/0009-9236(95)90168-X","article-title":"Differentiation of Absorption and First-Pass Gut and Hepatic Metabolism in Humans: Studies with Cyclosporine","volume":"58","author":"Wu","year":"1995","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nmeth.1455","article-title":"Coding of Facial Expressions of Pain in the Laboratory Mouse","volume":"7","author":"Langford","year":"2010","journal-title":"Nat. Methods"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Kwon, J., Lee, C., Heo, S., Kim, B., and Hyun, C.-K. (2021). DSS-Induced Colitis is Associated with Adipose Tissue Dysfunction and Disrupted Hepatic Lipid Metabolism Leading to Hepatosteatosis and Dyslipidemia in Mice. Sci. Rep., 11.","DOI":"10.1038\/s41598-021-84761-1"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/16\/7913\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:29:04Z","timestamp":1760034544000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/16\/7913"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,16]]},"references-count":82,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["ijms26167913"],"URL":"https:\/\/doi.org\/10.3390\/ijms26167913","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,16]]}}}